Christine Lu‐Emerson

1.7k total citations
19 papers, 551 citations indexed

About

Christine Lu‐Emerson is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Christine Lu‐Emerson has authored 19 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Christine Lu‐Emerson's work include Glioma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Acute Ischemic Stroke Management (3 papers). Christine Lu‐Emerson is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Acute Ischemic Stroke Management (3 papers). Christine Lu‐Emerson collaborates with scholars based in United States, China and Switzerland. Christine Lu‐Emerson's co-authors include Scott R. Plotkin, Sandeep Khot, Tracy T. Batchelor, April F. Eichler, Elizabeth R. Gerstner, Dan G. Duda, Kyrre E. Emblem, Rakesh K. Jain, Jennie Taylor and Jay S. Loeffler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of the Neurological Sciences.

In The Last Decade

Christine Lu‐Emerson

17 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Lu‐Emerson United States 8 234 169 129 126 119 19 551
László Mechtler United States 8 325 1.4× 172 1.0× 121 0.9× 164 1.3× 60 0.5× 21 567
Joseph D. DiDomenico United States 13 154 0.7× 168 1.0× 180 1.4× 166 1.3× 59 0.5× 34 566
Shruti Shrivastav United States 6 238 1.0× 171 1.0× 232 1.8× 175 1.4× 117 1.0× 15 555
Yukina Morimoto Japan 14 196 0.8× 125 0.7× 114 0.9× 126 1.0× 47 0.4× 33 483
Jian Xie China 16 190 0.8× 122 0.7× 137 1.1× 181 1.4× 55 0.5× 48 591
Yong Cui China 17 367 1.6× 168 1.0× 60 0.5× 196 1.6× 169 1.4× 59 831
Konstantinos Gousias Germany 13 301 1.3× 250 1.5× 71 0.6× 93 0.7× 109 0.9× 29 739
Raita Fukaya Japan 9 106 0.5× 148 0.9× 134 1.0× 114 0.9× 91 0.8× 19 502
Naema Nayyar United States 12 276 1.2× 218 1.3× 46 0.4× 220 1.7× 62 0.5× 26 690
Angelo Porciuncula United States 8 283 1.2× 136 0.8× 277 2.1× 285 2.3× 70 0.6× 11 648

Countries citing papers authored by Christine Lu‐Emerson

Since Specialization
Citations

This map shows the geographic impact of Christine Lu‐Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Lu‐Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Lu‐Emerson more than expected).

Fields of papers citing papers by Christine Lu‐Emerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Lu‐Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Lu‐Emerson. The network helps show where Christine Lu‐Emerson may publish in the future.

Co-authorship network of co-authors of Christine Lu‐Emerson

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Lu‐Emerson. A scholar is included among the top collaborators of Christine Lu‐Emerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Lu‐Emerson. Christine Lu‐Emerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Leung, Denise, Ashley Ghiaseddin, Jennie Taylor, et al.. (2024). Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients. Cancer. 130(9). 1577–1589. 1 indexed citations
2.
Anderson, Eric, F. Lee Lucas, Michael J. Hall, et al.. (2024). Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI). npj Precision Oncology. 8(1). 67–67. 3 indexed citations
3.
Walbert, Tobias, Edward K. Avila, Florien Boele, et al.. (2024). Symptom management in isocitrate dehydrogenase mutant glioma. Neuro-Oncology Practice. 12(Supplement_1). i38–i48. 1 indexed citations
4.
Rueter, Jens, Eric Anderson, Leah Graham, et al.. (2023). The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State. JCO Precision Oncology. 7(7). e2200619–e2200619. 4 indexed citations
5.
Sengupta, Soma, Michael Glantz, Christine Lu‐Emerson, et al.. (2022). Multi-institutional randomized phase 3 trial comparing cancer stem cell-targeted versus physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135).. Journal of Clinical Oncology. 40(16_suppl). 2028–2028. 2 indexed citations
6.
Lee, Eudocia Q., Lorenzo Trippa, Geoffrey Fell, et al.. (2022). Feasibility and conduct of INSIGhT, a platform trial of patients with glioblastoma using Bayesian adaptive randomization.. Journal of Clinical Oncology. 40(16_suppl). 2012–2012. 2 indexed citations
7.
Lu‐Emerson, Christine, et al.. (2017). Painful Trigeminal Neuropathy as a Rare but Important Presenting Complication of Metastasis of Head and Neck Cancer: A Case Report and Review. 2(1). 1 indexed citations
8.
Lu‐Emerson, Christine, Dan G. Duda, Kyrre E. Emblem, et al.. (2015). Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma. Journal of Clinical Oncology. 33(10). 1197–1213. 135 indexed citations
9.
Lu‐Emerson, Christine, Matija Snuderl, Nathaniel D. Kirkpatrick, et al.. (2013). Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro-Oncology. 15(8). 1079–1087. 177 indexed citations
10.
Lu‐Emerson, Christine & April F. Eichler. (2012). Brain Metastases. CONTINUUM Lifelong Learning in Neurology. 18(2). 295–311. 33 indexed citations
11.
Lu‐Emerson, Christine, Matija Snuderl, Christian J. Davidson, et al.. (2012). Effect of antiangiogenic therapy on tumor-associated macrophages in recurrent glioblastoma.. Journal of Clinical Oncology. 30(15_suppl). 2010–2010. 1 indexed citations
12.
Lu‐Emerson, Christine, Andrew D. Norden, Jan Drappatz, et al.. (2010). Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. Journal of Neuro-Oncology. 104(1). 287–291. 54 indexed citations
13.
Lu‐Emerson, Christine & Sandeep Khot. (2010). Neurological sequelae of hypoxic-ischemic brain injury. Neurorehabilitation. 26(1). 35–45. 49 indexed citations
14.
Lu‐Emerson, Christine, et al.. (2010). Management of ischemic stroke: Part 2. The inpatient stay. Journal of Hospital Medicine. 5(2). 88–93.
15.
Lu‐Emerson, Christine, Andrew D. Norden, Jan Drappatz, et al.. (2010). Retrospective study of dasatinib in recurrent high-grade glioma (HGG) patients who failed bevacizumab.. Journal of Clinical Oncology. 28(15_suppl). e12525–e12525. 1 indexed citations
16.
Lu‐Emerson, Christine, Melanie Walker, Bertrand R. Huber, et al.. (2010). Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy. Journal of the Neurological Sciences. 295(1-2). 120–124. 12 indexed citations
17.
Lu‐Emerson, Christine, et al.. (2010). Management of ischemic stroke: Part 1. Emergency room management. Journal of Hospital Medicine. 5(1). 33–40.
18.
Lu‐Emerson, Christine & Scott R. Plotkin. (2009). The neurofibromatoses. Part 2: NF2 and schwannomatosis.. PubMed. 6(3). E81–6. 43 indexed citations
19.
Lu‐Emerson, Christine & Scott R. Plotkin. (2009). The Neurofibromatoses. Part 1: NF1.. PubMed. 6(2). E47–53. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by László Mechtler Breakdown of academic impact, for papers by Joseph D. DiDomenico Breakdown of academic impact, for papers by Shruti Shrivastav Breakdown of academic impact, for papers by Yukina Morimoto Breakdown of academic impact, for papers by Jian Xie Breakdown of academic impact, for papers by Yong Cui Breakdown of academic impact, for papers by Konstantinos Gousias Breakdown of academic impact, for papers by Raita Fukaya Breakdown of academic impact, for papers by Naema Nayyar Breakdown of academic impact, for papers by Angelo Porciuncula
Rankless by CCL
2026